Welcome to Genvade Therapeutics

Read more

Genvade Therapeutics is supported by

BPI France

Vaincre la mucoviscidose

Eurasanté

Pôle Nutrition Santé et Longévité

Vaccine. Hands of a scientist, under a sterile hood, preparing the carcinoembryonic antigen (CEA) vaccinia used to try to prevent cancer. The scientist is diluting the concentrated vaccinnia virus into a dose level appropriate for administration to a patient. This vaccinnia marks any cancer cells expressing the CEA.

Welcome to our website

Genvade Therapeutics aims to harness the power of nonsense mutation readthrough molecules to develop treatments for some of the most burdensome rare diseases. Our lead compound targets indications include cystic fibrosis, Duchenne muscular dystrophy and other genetic diseases.